Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

GRK2-mediated cardiomyocyte signaling factors are responsible for heart-fat communication and mediate the development of cardiometabolic disease

FY 2023-24

Summary
In Canada and around the world, heart disease is the leading cause of death. People who are overweight or obese have a higher risk of heart disease. Therefore, we need to find new treatments for people who are overweight and have heart disease. To do this, we need to know how the heart and fat communicate with each other. The heart makes and releases factors that travel to other parts of the body, like fat tissue, to communicate important messages. When there is more fat, the heart sends more factors. We also know these factors can lower the amount of fat, but we don't know what these factors are. This research will study how the heart talks to fat and identify the factors, using cells and mice. We will isolate the factors released from heart cells and give them to fat cells to see if they reduce the amount of fat that accumulates. We will also study the factors released from the hearts of mice on a high fat diet. We will isolate the factors from mice and give them to fat cells to confirm they reduce the amount of fat. To confirm our findings, we will give the mice a drug that will prevent their hearts from producing the factors and study their weight gain. When we prevent the heart from producing these factors, the mice will gain weight. Using a method called mass spectrometry we will identify what the factors are. After identifying the factors, we can do more experiments to change the levels of the factors in mice. We will then study their weight gain to confirm our findings and the identity of the factor. This will help us create new drugs that treat both heart disease and obesity.
Program
CIHR Fellowship
Location
North Carolina, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
492890
Name
Kereliuk Stephanie M
Region
North Carolina
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
GRK2-mediated cardiomyocyte signaling factors are responsible for heart-fat communication and mediate the development of cardiometabolic disease
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Adipose; Cardiometabolic; Cardiovascular; Extracellular Vesicles; G Protein Coupled Receptor Kinase; Heart Disease; Heart Failure; Metabolism; Obesity; Signaling
Abstract
In Canada and around the world, heart disease is the leading cause of death. People who are overweight or obese have a higher risk of heart disease. Therefore, we need to find new treatments for people who are overweight and have heart disease. To do this, we need to know how the heart and fat communicate with each other. The heart makes and releases factors that travel to other parts of the body, like fat tissue, to communicate important messages. When there is more fat, the heart sends more factors. We also know these factors can lower the amount of fat, but we don't know what these factors are. This research will study how the heart talks to fat and identify the factors, using cells and mice. We will isolate the factors released from heart cells and give them to fat cells to see if they reduce the amount of fat that accumulates. We will also study the factors released from the hearts of mice on a high fat diet. We will isolate the factors from mice and give them to fat cells to confirm they reduce the amount of fat. To confirm our findings, we will give the mice a drug that will prevent their hearts from producing the factors and study their weight gain. When we prevent the heart from producing these factors, the mice will gain weight. Using a method called mass spectrometry we will identify what the factors are. After identifying the factors, we can do more experiments to change the levels of the factors in mice. We will then study their weight gain to confirm our findings and the identity of the factor. This will help us create new drugs that treat both heart disease and obesity.
Competitiondate
202310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kereliuk, Stephanie M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~